Evidence map›Paper›PMID 36528520›Full record

Trial reportThe Journal of adolescent health : official publication of the Society for Adolescent Medicine2023

Adolescent Knowledge of When to Use Inhaled Asthma Medications: Implications for Management.

Sean M Frey, Maria Fagnano, Jill S Halterman

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07364643 (Assessment of Asthma Management in Children Over 6 Years of Age and Their Caregivers. Implications for the Implementation of the SMART Strategy in Pediatrics.), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07364643 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Assessment of Asthma Management in Children Over 6 Years of Age and Their Caregivers. Implications for the Implementation of the SMART Strategy in Pediatrics.

TypeinterventionalSponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauRan2026 to 2027Enrolled428ConditionsAsthma ChildhoodArmsEducational Intervention
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sean M FreyDepartment of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York. Electronic address: Sean_Frey@urmc.rochester.edu.
Maria FagnanoDepartment of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York.
Jill S HaltermanDepartment of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York.
University of Rochester · US

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Martha Susiarjo · 1985 to 2026
$42.8M
School-Based Asthma Care for Teens (SB-ACT)R18HL116244 · NHLBI · UNIVERSITY OF ROCHESTER · PI HALTERMAN, JILL S · 2014 to 2018
$3.6M
NHLBI NIH HHS R18 HL116244NIEHS NIH HHS P30 ES001247
6 · The paper itself

Abstract

purposeIt is unclear how often adolescents with persistent asthma know when to use different inhaled medications (as-needed rescue vs. daily controller; 'accurate use'), or whether this knowledge is associated with clinical asthma outcomes. This study aimed to characterize adolescent knowledge of accurate use; examine whether accurate use is associated with controller medication adherence, asthma symptoms, or exacerbations requiring acute health care services; and determine whether knowledge of accurate use improves following regular exposure to controller medications with school-based directly observed therapy (DOT).

methodsWe analyzed baseline and 7-month data from the School-Based Asthma Care for Teens trial. Adolescents (12-16 years) identified inhaled medications on a chart and stated when each is used. We compared accurate use with adolescent-reported adherence, recent symptoms, and asthma-related acute health care visits; and exposure to DOT. Analyses were limited to subjects with controller medication.

resultsOf 430 participants, 252 had controller medication at baseline. Knowledge of accurate use was described by 62%, and associated with adherence (odds ratio [OR]: 2.06, 95% confidence interval [CI]: 1.12-3.83). By 7 months, 313 adolescents had controller medication; 75% described accurate use, which was associated with adherence (OR: 3.46, 95% CI: 1.83-6.54), health care (OR: 0.39, 95% CI: 0.20-0.79), and DOT exposure (OR: 1.83, 95% CI: 1.10-3.32). Associations with adherence and health care at 7 months persisted in adjusted analyses. DISCUSSION: Adolescent knowledge of accurate medication use was linked with greater adherence (baseline, 7 months), less acute health care (7 months), and exposure to in-school DOT. Interventions to support adolescents with persistent asthma should consider school-based care strategies and facilitate adolescent understanding of when to use different medications.

Indexed as

Anti-Asthmatic AgentsAsthmaAdolescentHealth FacilitiesHumansMedication AdherenceAnti-Asthmatic AgentsAdherenceAdolescentAsthmaIdentificationManagementMedicationRespiratoryTreatment

Identifiers

PMID36528520
PMCPMC10033387
OpenAlexW4311771060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.